3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Leukemia
2
Preleukemia
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Hematologic Diseases
1
Cytopenia
1
Bone Marrow Diseases
1
Anemia
1
Interventions
Epoetin Alfa
11
Lenalidomide
5
fludarabine phosphate
4
Cyclosporine
4
Cyclophosphamide
4
fludarabine
3
Filgrastim
3
Darbepoetin alfa
3
Busulfan
3
Antilymphocyte Serum
3
thymoglobulin
2
Thiotepa
2
Therapeutics
2
Surveys and Questionnaires
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Ferric Oxide, Saccharated
2
Biopsy
2
AP 1903 reagent
2
venetoclax
1
trametinib
1
ruxolitinib
1
regorafenib
1
ponatinib
1
pertuzumab
1
pembrolizumab
1
palbociclib
1
olaparib
1
obinutuzumab
1
neratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia
×
Sertraline
×
Other hematologic neoplasm
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled